Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12

Cited by (970)

Items 801–900 of 970

1. Ethyl Acetate Extract of Pereskia bleo Leaves Enhances Natural Killer Cells Activation and Cytotoxicity Against Cervical Cancer HeLa Cells
   Siti Farhanah Mohd-Salleh, Norzila Ismail, Yusoff Mn, Siew Hua Gan, Wan Suriyani Wan-Ibrahim, Jamaruddin Mat Asan, María E. Sarmiento, Armando Acosta · 2024 · Malaysian Journal of Medicine and Health Sciences
2. A path forward to improving the specificity of immunotherapies
   Brittany R. Barber, Florian Mair, Martin Prlic · 2022 · Clinical and Translational Medicine
3. Proximity-dependent labeling identifies dendritic cells that prime the antitumor CD4+ T cell response
   Gabriel D. Victora, Aleksey Chudnovskiy, Sandra Nakandakari-Higa, Tiago B. R. Castro, Ang Cui, Chia‐Hao Lin, Moshe Sade-Feldman, Brooke K. Phillips, Juhee Pae, Luka Mesin et al. · 2022 · Research Square
4. Correction of age-associated defects in dendritic cell functions enables CD4 + T cells to eradicate tumors in the elderly
   Dania Zhivaki, Francesco Borriello, Stephanie N. Kennedy, Charles Lee Evavold, Kristin M. Bahleda, Kate L. Chapman, Ivan Zanoni, Jonathan C. Kagan · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
5. Myeloid cell networks determine reinstatement of original immune environments in recurrent ovarian cancer
   Eleonora Ghisoni, Fabrizio Benedetti, Aspram Minasyan, Paula Cunnea, Alizée J Grimm, Noémie Fahr, Mathieu Desbuisson, Charlotte Capt, Nicolas Rayroux, D. Gulhan et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
6. Tumor-derived Extracellular Vesicles Induce ER Stress to Drive Tolerogenic Dendritic Cell Development in the Tumor Microenvironment
   X F Wang, Michael P. Plebanek, Y‐Van Nguyen, Mahere Rezazade Bazaz, Michael S. Sturdivant, Balamayooran Theivanthiran, Brent Allen Hanks · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
7. Anti-CD47 antibodies: A potential new cancer immunotherapy
   Da‐Liang Ou, Cheng-Zhe Jian, Guan-Sian Low, Liang‐In Lin · 2023 · Journal of Cancer Research and Practice
8. Combination of potassium oxonate with anti-PD-1 for the treatment of colorectal cancer
   Yuanyuan Wang, Chenxi Hu, Tianpeng Du, Jiawen Li, Kaiyuan Hui, Xiaodong Jiang · 2025 · Frontiers in Oncology
9. GMIP : A Novel Prognostic Biomarker Influencing Immune Infiltration and Tumour Dynamics Across Cancer Types
   Chao Jiang, Ningfeng Zhou, Xin Xu, Aochen Lv, Shenren Chang, Jiajie Wu, Xiang Li, Aijun Sun, Shiyan Wang, Wenze Tian · 2025 · Journal of Cellular and Molecular Medicine
10. Blocking Antibody Induced by Immunization with Hypoallergenic Derivatives of Scy p 1 Alleviated Mud Crab Allergy Symptoms
    Mengsi Li, Fei Xia, Qing-Mei Liu, Junfeng Zheng, Xin Guo, Li-Qiang Zhong, Gui-Xia Chen, Lianzhong Luo, Yixiang Liu, Guang‐Ming Liu · 2025 · Journal of Agricultural and Food Chemistry
11. From trash to treasure: tumor draining lymph nodes as a multi-omics goldmine in cancer therapy
    Yina Li, Zihan Chen, Guo Zhikun, Jiangnan Yu, Jianan Lu, Lei Wang, Qian Zhou · 2025 · Frontiers in Oncology
12. IL‐12 and the Antitumor Response: The Good, the Bad, and the Unknown
    Olivier Fesneau, Thomas Duhen · 2025 · BioEssays
13. A lymph node-targeted cell-nanoadjuvant conjugate enhances dendritic cell-T cell crosstalk for cancer immunotherapy
    Shuangshuang Hu, Wenzhe Yi, Zhiwen Zhao, Xindi Qian, Linyang Jiang, Ying Cao, Dan Yan, Lesheng Teng, Yaping Li · 2025 · Acta Pharmaceutica Sinica B
14. Injectable anti-inflammatory, antioxidant supramolecular nanofiber hydrogel for peripheral nerve injury repair and neuropathic pain relief
    Anqi Liu, Kui Sheng, Huihui Li, XinYang Zhao, X Zhang, Haitao Su, Tsring Samdrup, Ye Zhang, Xianwen Hu, LiJun Weng et al. · 2026 · Materials Today Bio
15. Noninvasive in vivo deoxycytidine kinase (dCK)-PET identifies tumor-draining lymph nodes upon immune checkpoint inhibitor therapy
    Cécile Philippe, Jonathan M. Cotton, Gregory D. Bowden, Simone Pöschel, Philipp Knopf, Barbara Francisca Schörg, Irene González-Menéndez, Dominik Sonanini, Lukas Flatz, Martin S Allen-Auerbach et al. · 2026 · npj Imaging
16. CX3CR1 identifies a potent effector CD8+ T cell subset associated with anti-PD-1 therapeutic efficacy in colorectal cancer
    Jiajin Ma, Yue Wu, Rongzhang Chen, Nuo Wang, Yirui Liu, L. Chen, Shaoxian Wu, Xiao Wei Zheng · 2026 · Frontiers in Immunology
17. A programmable nanoreactor for photothermal immunotherapy via NIR-II triggered enzyme-catalyzed immunogenic tumor microenvironment remodeling
    Jiayao Ding, Long Wang, Shengze Lu, Jingyang Su, Jingchao Li · 2026 · Asian Journal of Pharmaceutical Sciences
18. Nanoplasmid PSMA DNA vaccine primes antitumor immunity and enhances response to PD-1 blockade against prostate cancer
    Perry Ayn Mayson Maza, Leslie Flores, Dana Rae Cyril-Ramirez, Praveen Neeli, Haiwei Ni, Yong Li · 2026 · Cancer Letters
19. Vaccination-enabled immune readiness for checkpoint blockade
    Jhommara Bautista, Andrés López-Cortés · 2026 · Frontiers in Immunology
20. One-carbon metabolism in cancer immunity: T-cell fitness, epigenetic programming, and therapeutic opportunities
    Rongfei Wang, Naiwen Zhang, Runbing Xu, Zichen Xu, H. Li · 2026 · Frontiers in Immunology
21. Driving tumor-associated macrophages to a CXCL9Hi/SPP1Low phenotype eliminates pancreatic cancer
    Yen Thi Minh Nguyen, Marc Pfefferlé, Juhyun Oh, G. G. Simpson, S. A. Walker, Shingo Noguchi, Christopher S. Garris, Riley J. Deutsch-Williams, P. Wirapati, Federico De Stefano et al. · 2026 · Cell Reports Medicine
22. Bacteria-inspired mechano-chemical nanovaccines enable multi-activation of dendritic cells for potent antitumor immunity
    Hongjuan Zhao, Chenxi Zhao, Yuting Cang, Jinpei Sun, Qing Li, Keyu Zong, Yajing Wang, Di Meng, Qingling Song, Lei Wang · 2026 · Chemical Engineering Journal
23. Metabolic inflammation, obesity, and cancer
    Fawaz Alzaïd, Camille Blériot, Gerasimos Anagnostopoulos, Svetoslav Chakarov, Nicolas Venteclef, Florent Ginhoux · 2026 · Immunity
24. Kombination von Chemotherapie und autologen, Peptid‐beladenen dendritischen Zellen bringt Überlebensvorteil bei Melanompatienten im Stadium IV
    Klaus Eisendle, Georg Weinlich, Susanne Ebner, Markus Forstner, Daniela Reider, Claudia Zelle‐Rieser, Christoph H. Tripp, Peter O Fritsch, Patrizia Stoitzner, Nikolaus Romani et al. · 2020 · JDDG Journal der Deutschen Dermatologischen Gesellschaft
25. Single cell RNA sequencing reveals differentiation related genes with drawing implications in predicting prognosis and immunotherapy response in gliomas
    Zijian Zhou, Jinhong Wei, Zeruo Yang, Yue Bao, Wenbo Jiang, Bin Feng Lu, Weimin Wang, Li Luo · 2022 · Scientific Reports
26. Bioprospection and Clinical Investigations of Immunomodulatory Molecules
    Maria do Carmo Pimentel Batitucci, Jean Carlos Vencioneck Dutra, Judá BenHur de Oliveira, Mainã Mantovanelli da Mota, Paula Roberta Costalonga Pereira, Schirley Costalonga, Suiany Vitorino Gervásio, Vanessa Silva dos Santos · 2022 · Springer eBooks
27. De novo priming: driver of immunotherapy responses or epiphenomenon?
    Alexander L. Young, Tara Lorimer, Sarwah Al-Khalidi, Edward W. Roberts · 2023 · Essays in Biochemistry
28. Interferon-γ and tumor growth
    Andrej L Ilyushin, Богдашин Игорь Викторович, A. Z. Aleksanyan, Novikov Vv, L. А. Ashrafyan · 2023 · Siberian Journal of Oncology
29. Reliable prognostic definition and immunotherapy response prediction in bladder cancer, based on a novel aging-associated 5-gene signature model
    Wei Meng, Ningning Li, Bo Chen, Huajun Zhang, Limin Ma, Yangbo Guan · 2024 · Translational Andrology and Urology
30. New approaches to vaccines for cancer
    Vivek P. Chavda, Devarshi Acharya, Saloni Malla, Charles R. Ashby, Amit Kumar Tiwari · 2024 · Elsevier eBooks
31. Mouse Models Enable the Functional Investigation of Tertiary Lymphoid Structures in Cancer
    Advait Jeevanandam, Zixi Yin, Kelli A. Connolly, Nikhil S. Joshi · 2024 · Methods in molecular biology
32. Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 3rd–5th, 2020, Italy)
    Paolo A. Ascierto, Christian U. Blank, Reinhard Dummer, Marc S. Ernstoff, Soldano Ferrone, Bernard A. Fox, Thomas Frank Gajewski, Claus Garbe, Patrick Hwu, Paweł Kaliński et al. · 2021 · Journal of Translational Medicine
33. Alloantigen-activated (AAA) CD4+ T cells reinvigorate host endogenous T cell immunity to eliminate pre-established tumors in mice
    Kazuhiro Mochizuki, Shogo Kobayashi, Nobuhisa Takahashi, Kotaro Sugimoto, Hideki Sano, Yoshihiro Ohara, Shin Mineishi, Yi Zhang, Atsushi Kikuta · 2021 · Journal of Experimental & Clinical Cancer Research
34. Life support for transitory exhausted CTLs
    Asmaa Hamdi Mohamed, Yina H. Huang · 2021 · Trends in Immunology
35. IL-12 Signaling Promotes TET2-Mediated DNA Demethylation During CD8 T Cell Effector Differentiation
    Caitlin C. Zebley, Hossam Aly Abdelsamed, Hazem E. Ghoneim, Shanta Alli, Dalia Haydar, Tarsha L. Harris, Maureen Ann McGargill, Giedre Krenciute, Ben Youngblood · 2020 · SSRN Electronic Journal
36. 595 Inhibition of integrin αvβ8 in combination with low dose radiation induces antitumor effect in advanced immune checkpoint blockade refractory tumor model
    Natalia Reszka-Blanco, Megan T. Krumpoch, Michaela Mentzer, Vinod Yadav Yadav, Brianna Bannister, Dan Cui, Elizabeth H. Konopka, Dooyoung Lee, Fu‐Yang Lin, Terence I. Moy et al. · 2021 · Regular and Young Investigator Award Abstracts
37. Interferon-induced lysosomal membrane permeabilization and death cause cDC1-deserts in tumors
    Emmanouil Aerakis, Arsenios Chatzigeorgiou, M. Alvanou, M. Matthaiakaki-Panagiotaki, Ilias Angelidis, Dimitrios E. Koumadorakis, Αλέξανδρος Γαλάρας, Pantelis Hatzis, Dimitra Kerdidani, Manousos Makridakis et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
38. Spatial architecture of CD8 + T cells and DC subsets is critical for the response to immune checkpoint inhibitors in melanoma
    Élisa Gobbini, Margaux Hubert, Anne‐Claire Doffin, Anaïs Eberhardt, Léo Hermet, Danlin Li, Pierre Duplouye, Sarah Ghamry-Barrin, Justine Berthet, Valentin Benboubker et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
39. A CXCR4 partial agonist improves immunotherapy by targeting polymorphonuclear myeloid-derived suppressor cells and cancer-driven granulopoiesis
    Jin Qian, Chenkai Ma, Quin T. Waterbury, Xiaofei Zhi, Christine S. Moon, Ruhong Tu, Hiroki Kobayashi, Feijing Wu, Biyun Zheng, Yi Zeng et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
40. Mapping intratumoral myeloid-T cell interactomes at single-cell resolution reveals targets for overcoming checkpoint inhibitor resistance
    Kate Bridges, Gabriela A. Pizzurro, Alev Baysoy, Janani P. Baskaran, Ziyan Zoe Xu, Varsha Mathew, Victoria Tripple, Michael LaPorte, Koonam Park, William Damsky et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
41. Bystander IFN-y activity promotes widespread and sustained cytokine signaling altering the tumor microenvironment
    Ronan Thibaut · 2019 · theses.fr (ABES)
42. Immunomodulatory Drugs Encoded by Oncolytic Viruses: Is the Whole Greater Than the Sum?
    Dmitriy Zamarin · 2019 · Molecular Therapy
43. Dendritic Cells and Their Roles in Anti-Tumour Immunity
    Ee Shan Pang, Christophe Macri, Timothy Patton, Mariam Bafit, Meredith A O’Keeffe · 2020 · IntechOpen eBooks
44. Systemic Correlates of the Tumor Microenvironment
    Lei Wang, Peter P. Lee · 2020 · Cancer treatment and research
45. The clonal and molecular aetiology of emergency dendritic cell development
    Dawn S. Y. Lin, Luyi Tian, Sara Tomei, Daniela Amann‐Zalcenstein, Tracey M. Baldwin, Tom Weber, Jaring Schreuder, Olivia J. Stonehouse, Jai Rautela, Nicholas D. Huntington et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
46. Single-cell sequencing characterizes intratumoral profile of immune cells in old mice
    Cangang Zhang, Lei Lei, Xiaofeng Yang, Huiqiang Zheng, Yanhong Su, Anjun Jiao, Xin Wang, Haiyan Liu, Yujing Zou, Lin Shi et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
47. Mechanisms of Resistance to Immunotherapy in Cutaneous Melanoma
    Andrea Anichini, Roberta Mortarini · 2021 · Springer eBooks
48. In Situ Transfection of Interleukin 12 Plasmid Enhances Anti-PD-1 Immune Response in Patients with Immunologically Quiescent Melanoma
    Alain Patrick Algazi, Chris Twitty, Katy K. Tsai, Mai Hope Le, Robert Hamilton Pierce, Jean S. Campbell, Erica Browning, Renata Hermiz, Dave Canton, Donna Bannavong et al. · 2019 · SSRN Electronic Journal
49. Association Between FSIP2 Mutation and an Improved Prognosis in Patients With Skin Cutaneous Melanoma Treated With Immune Checkpoint Inhibitors
    Haoxuan Ying, Anqi Lin, Jian Zhang, Peng Luo · 2020
50. LONG-TERM UNDERSTANDING THROUGH SHORT-TERM MISUNDERSTANDING: THE MEANING OF INTERACTIVE-TRANSCRIPTIVE DISTURBANCE HANDLING FOR THE TRANSFER OF KNOWLEDGE
    M. Haarich, Ingo Leisten, Alphons J. Richert, Sabina Jeschke · 2012 · EDULEARN proceedings
51. Distinct cDC subsets co-operate in CD40 agonist response while suppressive microenvironments and lack of antigens subvert efficacy
    Aleksandar Murgaski, Máté Kiss, Helena Van Damme, Daliya Kancheva, Isaure Vanmeerbeek, Jiri Keirsse, Éva Hadadi, Jan Brughmans, Sana M. Arnouk, Ahmed E.I. Hamouda et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
52. Maximizing the Anti-tumor Potential of Immune Checkpoint Blockade through Modulation of Myeloid-specific CXCL16 and STAT1 Signaling
    Bhavana Palakurthi, Ian Hunter Guldner, Xiyu Liu, Anna K. Martino, Qingfei Wang, Shaneann R. Fross, Ryan A. Neff, Samantha M. Golomb, Erin N. Howe, Siyuan Zhang · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
53. Ranitidine as adjuvant regulates macrophage polarization and activates CTL through PI3K-Akt2 signal pathway
    Ling Li, Chenglin Li Li, Shuang Wang, Xiaoran Ma, Tiantian Wang, Xihui Jia, Ran Lu, Zhe Leng, Xiaowen Kong, Jinyu Zhang · 2022 · Research Square
54. RNF8 enhances the sensitivity of PD-L1 inhibitor against melanoma through ubiquitination of galectin-3 in stroma
    Degui Wang, yanan guo, Rong Shen, keren Yang, yutong Wang, Haoyun Song, Xiangwen Liu, xin Cheng, Rile Wu, Yanfeng Song · 2023 · Research Square
55. Positive Correlation between PMS2 Deficiency and PD-L1 Expression in Pancreatic Cancer
    Cailing Jiang, Chunyan Dang, Ruilong He, Limin Cheng, Yiying Bai, Xinyu Bai, Xin Wang, Qianhui Chen, Hongbin Yang, Zhengxin Zhang et al. · 2023 · Advances in Bioscience and Biotechnology
56. Data from Efficacy of CD40 Agonists Is Mediated by Distinct cDC Subsets and Subverted by Suppressive Macrophages
    Aleksandar Murgaski, Máté Kiss, Helena Van Damme, Daliya Kancheva, Isaure Vanmeerbeek, Jiri Keirsse, Éva Hadadi, Jan Brughmans, Sana M. Arnouk, Ahmed E.I. Hamouda et al. · 2023
57. Data from Efficacy of CD40 Agonists Is Mediated by Distinct cDC Subsets and Subverted by Suppressive Macrophages
    Aleksandar Murgaski, Máté Kiss, Helena Van Damme, Daliya Kancheva, Isaure Vanmeerbeek, Jiri Keirsse, Éva Hadadi, Jan Brughmans, Sana M. Arnouk, Ahmed E.I. Hamouda et al. · 2023
58. Modification and Immune Function of Porcine PD-1 and PD-L1 Interaction Epitope Peptides
    Feng Yue, Yeping Shi, Juanjuan Zhou, Yanping Zhu, Dongguang Guo, Liming Xia, Xueying Yang, Xuannian Wang · 2023 · Research Square
59. Immunomodulation under the lens of real‐time in vivo imaging
    Philippe Bousso, Capucine L. Grandjean · 2023 · European Journal of Immunology
60. Immunotherapy and Cancer Stem Cells
    Ravi Teja Chitturi Suryaprakash, Mohammad Ayman Abdulkarim Safi, Noufa Afri Alonazi, Ahdab A. Alsieedi, Omar Kujan · 2023 · BENTHAM SCIENCE PUBLISHERS eBooks
61. Screening and validation of plasma cell-derived, purinergic, and calcium signalling-related genetic signature to predict prognosis and PD-L1/PD-1 blockade responses in lung adenocarcinoma
    Junfeng Huang, Xingyu Fan, Bingqi Hu, Liwen Chen · 2023 · Journal of Cancer Research and Clinical Oncology
62. Molecular typing and prognostic risk models for ovarian cancer: a study based on cell differentiation trajectory
    Tingfeng Chen, Tingting Ni, Lan Mu, Zhou Ying, Hanqun Zhang, Zi Wang · 2023 · Frontiers in Cell and Developmental Biology
63. Combined blockade of CXCR4 and PD-1 enhances intratumoral dendritic cell activation and immune responses against HCC
    Satoru Morita, Kohei Shigeta, Pin‐Ji Lei, Tatsuya Kobayashi, Hiroto Kikuchi, Aya Matsui, Peigen Huang, Mikaël J. Pittet, Dan Gabriel Duda · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
64. DC-T cell axis is an effective target for treating non-small cell lung cancer
    Shuangcui Wang, Guan Zhang, Qian Cui, Yanjie Yang, Dong Wang, Aqing Liu, Ying Xia, Wentao Li, Yunhe Liu, Jianchun Yu · 2024
65. Additional file 4 of Machine learning-derived identification of tumor-infiltrating immune cell-related signature for improving prognosis and immunotherapy responses in patients with skin cutaneous melanoma
    Shaolong Leng, Gang Nie, Changhong Yi, Yunsheng Xu, Lvya Zhang, Linyu Zhu · 2023 · Figshare
66. Additional file 3 of Machine learning-derived identification of tumor-infiltrating immune cell-related signature for improving prognosis and immunotherapy responses in patients with skin cutaneous melanoma
    Shaolong Leng, Gang Nie, Changhong Yi, Yunsheng Xu, Lvya Zhang, Linyu Zhu · 2023 · Figshare
67. Additional file 1 of Identification of stem cell-related subtypes and risk scoring for gastric cancer based on stem genomic profiling
    Renshen Xiang, Wei Song, Jun Tao Ren, Jing Wu, Jincheng Fu, Tao Fu · 2021 · Figshare
68. Additional file 2 of Machine learning-derived identification of tumor-infiltrating immune cell-related signature for improving prognosis and immunotherapy responses in patients with skin cutaneous melanoma
    Shaolong Leng, Gang Nie, Changhong Yi, Yunsheng Xu, Lvya Zhang, Linyu Zhu · 2023 · Figshare
69. Additional file 1 of Machine learning-derived identification of tumor-infiltrating immune cell-related signature for improving prognosis and immunotherapy responses in patients with skin cutaneous melanoma
    Shaolong Leng, Gang Nie, Changhong Yi, Yunsheng Xu, Lvya Zhang, Linyu Zhu · 2023 · Figshare
70. Engineered oncolytic virus oHSV2-FLT3L enhances antitumor immunity via dendritic cell activation
    Duo Wan, Qi Zhang, Zhenrong Yang, Xiaoli Zhang, Peipei Xie, Shujun Cheng, Libin Xu, Binlei Liu, Kaitai Zhang, Wen Zhang · 2025 · Molecular Therapy Oncology
71. Emerging Biomarkers of Response to Immunotherapy: Host Characteristics in Breast Cancer
    Vivek Mathesh, Sangeetha Meda Reddy · 2025 · Cancer immunotherapy
72. Monocitos, macrófagos y células dendríticas en homeostasis y patología
    Ángeles Domínguez‐Soto, Angel Luis Corbí, A. Miranda, R. Sánchez Martín, M. Álvarez-Mon, J. Monserrat Sanz · 2025 · Medicine - Programa de Formación Médica Continuada Acreditado
73. A frameshift-generated cancer neoepitope that controls tumor burden in prophylaxis as well as therapy
    Mariam Mathew George, Cory A Brennick, Adam T. Hagymasi, Tatiana V. Shcheglova, Sahar Al Seesi, Tatiana J. Rosales, Brian M. Baker, Ion Măndoiu, Pramod Kumar Srivastava · 2025 · The Journal of Immunology
74. The Immunoradiotherapy in Nasopharyngeal Carcinoma
    Jingjing Miao, Caifei Xiang, Chuchu Liu · 2025 · Springer eBooks
75. Exosomal ITGB2 Mediates Immune Evasion in Triple-Negative Breast Cancer by Suppressing Dendritic Cell Activation via TLR4
    Puerkaiti Paierhati, Binlin Ma, Muzhapaer Abudukeremu · 2025 · Iranian Journal of Public Health
76. Novel IL13RA2-targeted immunocytokines exhibit superior antitumor activities
    Qing Jing, Jing Wen, Jian-xia Ou, Yanting He, Yuting Zhang, Gul E. Rana, Qi Wang, Guifeng Wang, Chunhe Wang · 2025 · Acta Pharmacologica Sinica
77. Alphavirus replicon particle expressing IL-12 reprograms tumor-associated macrophages and neutrophils and induces anti-tumor immunity
    Momoko Ishikawa, Dhanya K. Nambiar, Jaya Sastri, Forrest Bowling, Keiko Ishimoto, Fumiya Tao, Koyo Takahashi, Ivan Stephanek, Hongbin Cao, Davis Leitner et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
78. Oncolytic HSV-1 expressing FLT3L kills melanoma, glioblastoma, and pancreatic cancer cells in vitro and induces immunogenic cell death
    Sandra Tuyaerts, Xenia Geeraerts, Alberto Reale, Latoya Stevens, Giada Bertazzon, Jack Brons, Toon Janssen, Ivan Van Riet, Arianna Calistri, Bart Neyns · 2025 · Molecular Therapy Oncology
79. Drug allergy history predicts early progression-free survival benefit from PD-(L)1 inhibitors in advanced non-small cell lung cancer: a retrospective cohort study
    Wenhao Zhao, Min Yu, Youling Gong, Meijuan Huang, Jianxin Xue, You Lü · 2025 · Clinical & Translational Oncology
80. The antitumor mechanism of immuno-flap treatment in a rat model of head and neck cancer
    Hiroaki Mori, Yasuto Akiyama, Chie Maeda, Akari Kanematsu, Tadashi Ashizawa, Kazue Yamashita, Haruo Miyata, Akira Iizuka, Tomoatsu Ikeya, Yoshichika Yasunaga et al. · 2025 · Cancer Immunology Immunotherapy
81. Integrating Mathematical and Mouse Models Identifies T Regulatory Cell Influx as A Key Determinant of Acquired Resistance to PD-1 Immunotherapy
    Rachel S Sousa, Shannon N Geels, Claire Murat, Alexander Moshensky, S. Armando Villalta, John S. Lowengrub, Francesco Marangoni · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
82. Recurrent RNA-Lipoplex Vaccination Is Required To Sustain Functional Tumor-Infiltratingneoantigen-Specific CD8 T Cells and Therapeutic Efficacy
    Justin Tyler Gibson, Milena Hornburg, Sophie M. Lehar, Vincent Javinal, Lisa Liao, Mark J. McCarron, Tamaki Nozawa Jones, Yoko A. Oei, Debra Y. Dunlap, Kevin A. Marroquin et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
83. CD74 regulates antitumor immunity in melanoma by reprogramming dendritic cell immunogenicity and migration
    Eleftheria Maranou, Ga‐Young Park, Pauline Weinzettl, Jonna Alanko, Otto I. Pulkkinen, Sarah E. Coupland, Marko Salmi, Carlos R. Figueiredo · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
84. Leukemic Transdifferentiation: From Pathological Plasticity to Dendritic Cell-Based Immunotherapy
    Joanna Dubis, Aleksander Czogalla, Kazimierz Kuliczkowski, Aleksander F. Sikorski · 2025 · Biomedicines
85. Additional file 1 of Peptide vaccine-conjugated mesoporous carriers synergize with immunogenic cell death and PD-L1 blockade for amplified immunotherapy of metastatic spinal
    Wang, Zhenqing, Liang Chen, Ma, Yiqun, 李熙雷, Hu, Annan, Wang, Huiren, Wang, Wenxing, Li, Xiaomin, Tian, Bo, Dong, Jian · 2021 · Figshare
86. Additional file 6 of Machine learning-derived identification of tumor-infiltrating immune cell-related signature for improving prognosis and immunotherapy responses in patients with skin cutaneous melanoma
    Shaolong Leng, Nie, Gang, Changhong Yi, Xu, Yunsheng, Lvya Zhang, Linyu Zhu · 2023 · Figshare
87. Additional file 1 of Development of dendritic cell loaded MAGE-A2 long peptide; a potential target for tumor-specific T cell-mediated prostate cancer immunotherapy
    Parisa Bakhshi, Maryam Nourizadeh, Laleh Sharifi, Farajollahi, Mohammad M., Monireh Mohsenzadegan · 2024 · Figshare
88. Additional file 1 of Alloantigen-activated (AAA) CD4+ T cells reinvigorate host endogenous T cell immunity to eliminate pre-established tumors in mice
    Kazuhiro Mochizuki, Kobayashi, Shogo, Nobuhisa Takahashi, Kotaro Sugimoto, Hideki Sano, Yoshihiro Ohara, Shin Mineishi, Zhang, Yi, Atsushi Kikuta · 2021 · Figshare
89. Additional file 2 of Identification of stem cell-related subtypes and risk scoring for gastric cancer based on stem genomic profiling
    Xiang, Renshen, Song, Wei, Ren, Jun, Wu, Jing, Fu, Jincheng, Fu, Tao · 2021 · Figshare
90. Additional file 2 of Development of dendritic cell loaded MAGE-A2 long peptide; a potential target for tumor-specific T cell-mediated prostate cancer immunotherapy
    Parisa Bakhshi, Maryam Nourizadeh, Laleh Sharifi, Farajollahi, Mohammad M., Monireh Mohsenzadegan · 2024 · Figshare
91. Additional file 5 of Machine learning-derived identification of tumor-infiltrating immune cell-related signature for improving prognosis and immunotherapy responses in patients with skin cutaneous melanoma
    Shaolong Leng, Gang Nie, Changhong Yi, Xu, Yunsheng, Lvya Zhang, Linyu Zhu · 2023 · Figshare
92. Additional file 1 of Targeting the myeloid checkpoint receptor SIRPα potentiates innate and adaptive immune responses to promote anti-tumor activity
    Kuo, Tracy C., Chen, Amy, Ons Harrabi, Jonathan T. Sockolosky, Zhang, Anli, Emma Sangalang, Laura V. Doyle, Steven E. Kauder, Danielle A. Fontaine, Sangeetha Subbarao Bollini et al. · 2020 · Figshare
93. Additional file 1 of Synergistic effects of Smac mimetic APG-1387 with anti-PD-1 antibody are attributed to increased CD3 + NK1.1 + cell recruitment secondary to induction of cytokines from tumor cells
    Pan, Wentao, Luo, Qiuyun, Liang, Eric, Mude Shi, Jian Sun, Huimin Shen, Lu, Zhenhai, Zhang, Lin, Yan Xianglei, Luping Yuan et al. · 2024 · Figshare
94. Additional file 3 of Development of dendritic cell loaded MAGE-A2 long peptide; a potential target for tumor-specific T cell-mediated prostate cancer immunotherapy
    Parisa Bakhshi, Maryam Nourizadeh, Laleh Sharifi, Farajollahi, Mohammad M., Monireh Mohsenzadegan · 2024 · Figshare
95. Identification of the immunotherapy susceptibility of solid cancer using noninvasive in vivo bioluminescence optical imaging of NF-κB activation for precision medicine
    Dimitri Stowbur, Roman Mehling, Philipp Knopf, Barbara Francisca Schörg, Dominik Sonanini, Danielle Arnold-Schild, Irene González-Menéndez, Priv.Doz.Dr. Leticia Quintanilla-Martinez, Birgit Fehrenbacher, Martin Schaller et al. · 2025 · Research Square
96. Prognostic Implications of Chemokine Signaling Pathway Mutations for Immune Checkpoint Inhibitor Therapy in Colon Adenocarcinoma
    Deepak Verma, Ankit Bansal, Rakesh Sharma, Sunil Mehta · 2025 · Specialty journal of Pharmacognosy Phytochemistry and Biotechnology
97. Rewiring Dendritic Cell Immunity: The β-Catenin–TIM-3 Axis as a Target to Improve DC Cancer Vaccines
    Chunmei Fu, Tianle Ma, Li Zhou, Qing‐Sheng Mi, Aimin Jiang · 2026 · Cancers
98. Cell Communication Network factor 4 promotes tumor-induced immunosuppression in breast cancer
    David J. Klinke, Atefeh P. Razazan, Anika Pirkey, Wentao Deng · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
99. Multi-Omics Reveals Activated Fibroblasts with Dual Functional Roles in Repair and Negative Barrier in the CD8 + T Cell Cytotoxic Niche for Lung Cancer Neoadjuvant Therapy
    Ruihan Zhou, Chaoxin Xiao, Ping Zhou, Ouying Yan, Banglei Yin, Xiaohong Yao, Jiaxin Liu, Xuexue Wu, WW Hou, Yulin Wang et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
100. Tumor-Specific MHC Class II Expression Does Not Predict Benefit from Single-Agent PD-1 Blockade in Metastatic pMMR Colorectal Cancer
     Giulia J. Miller, Michael P. Gonzalez, Yuki L. Santos, Sofia Romano, Jun H. Smith · 2022 · Asian journal of Current Research in Clinical Cancer